Swiss drugmaker Novartis has announced 5.65bn euros ($7.4bn; Â£3.9bn) of purchases to make its Sandoz unit the world's biggest generic drug producer.Novartis said that it would be able to make cost savings of about $200m a year following the acquisitions.Novartis said that it would merge a number of departments, adding that there may be job cuts.The deal will see Novartis' Sandoz business overtake Israel's Teva Pharmaceuticals as the world's biggest maker of generics.Novartis, which last month forecast record sales for 2005, said it had bought all of Germany's Hexal.Novartis' shares rose 1% to 57.85 Swiss francs in early trading.